Creating the future of medicine in the Bay Area
At AbbVie, we are combining our historic legacy in biopharma with the spirit of California innovation. Our team in South San Francisco is pushing the limits of science and technology and driving the discovery and delivery of innovative treatments for cancer.
AbbVie’s campus is minutes away from hundreds of life sciences companies in South San Francisco, offering unlimited opportunities for scientific collaboration
A warm welcome for visitors and more than 1,000 Bay Area employees
Spaces built for teamwork and collaboration
Our labs in the Bay Area are an integral part of our global R&D ecosystem, which includes centers in Illinois, Massachusetts, Germany, and Japan
A pedestrian-friendly Gateway Central Park offers space to hold outdoor meetings, grab coffee, and enjoy fresh air
Fitness facilities, group classes, and dining areas available for employees
Space for collaboration with colleagues while having coffee or a meal
Committed to transforming standards of care
by advancing cancer research and the development of new treatments for a range of blood and other forms of cancer
State-of-the-art-facility
with 480,000 square feet of R&D labs and offices
On-site amenities
including the 50,000 square feet Traverse amenity building next door, offering a communal food hall, fitness club, and gathering space
Pioneering breakthroughs for patients
We discover and develop innovative medicines that help solve serious health issues for people around the world. In South San Francisco, we are driving AbbVie’s leadership in oncology and immunology, and using precision medicine to unlock more targeted treatments for patients. Beyond South San Francisco, we have a presence throughout the Bay Area, which includes sites that became part of AbbVie through our acquisition of Allergan in 2020.
Our unrelenting spirit of innovation
Dynamic scientific minds with strong values are essential to delivering on the promise of our R&D efforts. We are a passionate, diverse, equitable, and inclusive organization with a culture that supports bold ideas. With global opportunities in more than 175 countries and 60 disease areas, AbbVie provides challenging work that aims to deliver life-changing impact for patients.
Our work spans from early research and discovery to delivery of our medicines with focus areas in:
- Immuno-Oncology
- Tumor Targeting
- Tumor Dependencies
- Precision Medicine
Related Content
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.
Copyright © 2024 AbbVie Inc. North Chicago, Illinois, U.S.A.
